{"TopicDetails": {"type": 0, "ccm2Id": 31073856, "cftId": 0, "identifier": "IMI2-2015-08-01", "title": "Ebola and other filoviral haemorrhagic fevers (Ebola+) programme: future outbreaks", "publicationDateLong": 1450396800000, "callIdentifier": "H2020-JTI-IMI2-2015-08-single-stage", "callTitle": "H2020-JTI-IMI2-2015-08-single-stage", "callccm2Id": 31073866, "allowPartnerSearch": true, "workProgrammepart": {"id": 3051, "ccm_id": 31078048, "wp_part": "H2020-JTI-IMI-2016", "wp_year": "H2020-JTI-IMI-2016", "wp_title": "IMI2 Work Plan 2016", "wp_website": "http://www.imi.europa.eu/", "wp_document": "http://ec.europa.eu/research/participants/data/ref/h2020/other/wp/jtis/h2020-wp16-imi_en.pdf"}, "frameworkProgramme": {"id": 31045243, "abbreviation": "H2020", "description": "Horizon 2020 Framework Programme"}, "programmeDivision": [{"id": 31047894, "abbreviation": "EU.3.1.", "description": "Health, demographic change and wellbeing"}, {"id": 31047893, "abbreviation": "EU.3.", "description": "Societal Challenges"}, {"id": 31045244, "abbreviation": "EC", "description": "EC Treaty"}], "topicMGAs": [], "tags": ["deployment of vaccination regimens", "filoviral haemorrhagic fevers", "Clinical trials", "treatments and diagnosis of Ebola or other filovirus infections", "pre-clinical development and/or Phase 1, 2, and 3", "Ebola", "adaptable platforms", "vaccine"], "keywords": ["Global health", "Diagnostic tools (e.g. genetic, imaging)", "Emerging Epidemics", "Vaccines"], "flags": ["IntlCoop"], "sme": false, "actions": [{"status": {"id": 31094503, "abbreviation": "Closed", "description": "Closed"}, "types": [{"typeOfAction": "IMI2-RIA Research and Innovation action", "typeOfMGA": []}], "plannedOpeningDate": "18 December 2015", "submissionProcedure": {"id": 31094504, "abbreviation": "multiple cut-off", "description": "multiple cut-off"}, "deadlineDates": ["16 March 2016", "15 September 2016", "16 March 2017", "14 September 2017", "15 March 2018"]}], "latestInfos": [{"approvalDate": "Jun 20, 2017 4:59:20 PM", "lastChangeDate": "Jun 20, 2017 4:59:20 PM", "content": "<p>&nbsp;In order to fully address the objectives of the IMI2 Ebola+ programme as a programmatic approach addressing different challenges across the entire innovation cycle and aiming at leveraging input and multi-disciplinary expertise across stakeholders, potential applicants are also strongly encouraged to consider the opportunities offered through the Call for proposals that will be launched in parallel by the CEPI alliance (Coalition for Epidemic Preparedness Innovations http://cepi.net).</p>\r\n<p>In line with the IMI2 Call 8 topic text, this would offer the foundation for constructive synergies and complementarities with other projects and initiatives focusing on preparedness to react to future outbreaks of Ebola and other filoviral haemorrhagic fevers. This would also avoid duplication of efforts and to create collaboration at a global level to maximise European added value in health research.</p>"}], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3228154": [{"action": "IMI2-2015-08-01 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "18 December 2015", "deadlineModel": "multiple cut-off", "deadlineDates": ["16 March 2016", "15 September 2016", "16 March 2017", "14 September 2017", "15 March 2018"], "budgetYearMap": {"2015": 70000000}, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2015"]}, "description": "<SPAN class=\"topicdescriptionkind\">Specific Challenge</SPAN>:<p>The recent outbreak of Ebola virus disease (EVD) in West Africa underscores the vulnerability of populations worldwide to pathogens such as filoviral viruses. Currently, there are no vaccines or antiviral drugs approved for prevention or treatment of filoviral infections in humans. </p>\n<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p>This Call provides an opportunity to capture emerging scientific advances and to progress those rapidly into health care interventions. Proposals may address aspects of pre-clinical development and/or Phase 1, 2, and 3 clinical developments of vaccines (in particular multivalent), treatments and diagnosis of Ebola or other filovirus infections. Manufacturing strategies, vaccine stability during transport and storage, and/or deployment of vaccines and treatments are also in scope. Proposals for the development of adaptable platforms, which in addition to filoviruses can address multiple other priority pathogens, are also eligible.</p>\n<SPAN class=\"topicdescriptionkind\">Expected Impact</SPAN>:<p>Proposals must contribute to the objectives of IMI2 and in particular to the goals of the Ebola+ programme which is a programmatic approach addressing different challenges across the entire innovation cycle and aims at leveraging input and multidisciplinary expertise across stakeholders.</p><p>Specifically, proposals must increase the readiness to respond to future outbreaks of Ebola and other filoviral haemorrhagic fevers.</p><p>An important expected impact of projects funded under this Call must be to maximise the benefit to the people in the countries at risk from future outbreaks of filoviral haemorrhagic fevers. In order to achieve this, successful applicant consortia should have the capability to accelerate their project results into health care interventions.</p><p>Furthermore, proposals are expected to take advantage of and exploit support from different stakeholders with the necessary expertise, including the mobilization of funds through the inclusion of contributing partners under the IMI scheme of public-private consortia. Such contributing partners might include EFPIA companies or organizations associated to EFPIA, and Associated Partners to IMI. The budgeted cost for the participation of such partners is expected to account for at least 40% of the total project cost.</p><p>Projects are expected to have a significant impact on global health, both at the individual and the public health level by leading to results that have a direct impact for persons at risk of exposure to filoviral diseases or for patients suffering from filoviral disease.</p>\n<SPAN class=\"topicdescriptionkind\">Cross-cutting Priorities</SPAN>:<p><a href=\"//ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-search;statusCodes=31094501,31094502,31094503;programCcm2Id=31045243;crossCuttingPriorityCode=IntlCoop;sortQuery=sortStatus;orderBy=asc\">International cooperation</a><br></p>\n", "conditions": "<p>Please read carefully all provisions below before the preparation of your application :</p>\r\n<p>You can access the <strong>full&nbsp;</strong><strong>description of the topic</strong> in the <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/call_fiches/jtis/h2020-call-fiche15-8-imi2-ju_en.pdf\">Call topic text</a>.</p>\r\n<p>The budget breakdown for this Call is given in the <strong>Call Conditions</strong> section at the end of the <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/call_fiches/jtis/h2020-call-fiche15-8-imi2-ju_en.pdf\">Call topic text</a> (page 9) as well as the following information :&nbsp;<br />\r\n&nbsp;</p>\r\n<ol>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">List of countries and applicable rules for funding</span></strong><br />\r\n    &nbsp;</li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Eligibility and admissibility conditions</span></strong><br />\r\n    &nbsp;</li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Evaluation criteria and procedure, scoring and threshold:</span></strong> described in the <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/guides_for_applicants/jtis/h2020-guide-pse-imi-ju-call8_en.pdf \" target=\"_blank\">IMI Manual for Submission, Evaluation adn Grant award&nbsp;</a><br />\r\n    &nbsp; &nbsp; &nbsp;&nbsp;</li>\r\n    <li><span style=\"color: rgb(0,51,102)\"><strong>Indicative timetable for evaluation and grant agreement</strong></span><br />\r\n    &nbsp;</li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Provisions, proposal templates and evaluation forms for the type of action under this topic: </span></strong><br />\r\n    <br />\r\n    <u>IMI2 Research and Innovation Action (IMI2-RIA) and (IMI2-IA):</u><br />\r\n    <br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/guides_for_applicants/jtis/h2020-guide-rel-prov-imi-ju_en.pdf\">Summary of the most relevant provisions for participating in IMI2 actions</a><br />\r\n    <a href=\"http://ec.europa.eu/research/participants/portal/doc/call/h2020/imi2-2015-03-01/1635128-imi2_proposal-template_ria-ia_en.pdf\">Standard proposal template</a><br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/call_ptef/ef/h2020-call-ef-imi2-ria-ia-2016_en.pdf\">Standard evaluation form</a><br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/mga/jtis/h2020-mga-imi_en.pdf\">IMI2 Model Grant Agreement</a><br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/legal/templ/h2020_tmpl-clinical-studies_en.pdf\" target=\"_blank\">Template for Essential Clinical Trials Information</a>&nbsp;</li>\r\n</ol>", "supportInfo": "<p>Contact the <strong>IMI Progamme Office</strong> : <u>E-mail </u>:<strong>&nbsp;</strong><a href=\"mailto:Infodesk@imi.europa.eu\"><strong>applicants@imi.europa.eu</strong></a>&nbsp;</p>\r\n<p>Contact the <a href=\"http://ec.europa.eu/research/participants/portal/desktop/en/home.html\" target=\"_blank\">Participant Portal Helpdesk</a><strong>&nbsp;</strong>for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc...<br />\r\n<strong><br />\r\n</strong><a href=\"http://www.imi.europa.eu/content/states-representatives-groups\"><strong>IMI States Representative Group (SRG)</strong></a> &ndash; contact you <strong>SRG member</strong> for assistance.</p>\r\n<p><a href=\"http://www.imi.europa.eu/content/partner-search\"><strong>IMI Partner Seach Tool</strong></a> - find a <strong>partner </strong>organisation for your proposal&nbsp;</p>\r\n<p><strong><a href=\"http://ec.europa.eu/research/participants/portal4/desktop/en/support/national_contact_points.html\">National Contact Points (NCP)</a>&nbsp;-&nbsp;</strong>contact your <strong>NCP </strong>for further assistance.</p>\r\n<p><a href=\"http://een.ec.europa.eu/\"><strong>Enterprise Europe Network</strong></a> - contact your <strong>EEN </strong>national <strong>contact </strong>for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.</p>\r\n<p><a href=\"http://ec.europa.eu/research/index.cfm?lg=en&amp;pg=enquiries\"><strong>Research Enquiry Service</strong></a> - ask questions about any aspect of <strong>European research</strong> in general and the <strong>EU Research Framework Programmes in particular</strong></p>\r\n<p><strong>Ethics </strong>- to ensure compliance with ethical issues, check the information available on the <a href=\"http://ec.europa.eu/research/participants/docs/h2020-funding-guide/cross-cutting-issues/ethics_en.htm\">Participant Portal</a>, on the <a href=\"http://ec.europa.eu/research/swafs/index.cfm?pg=policy&amp;lib=ethics\">Sciences and Society Portal</a> and in the <a href=\"http://ec.europa.eu/euraxess/pdf/brochure_rights/am509774CEE_EN_E4.pdf\">European Charter for Researchers and the Code of Conduct for their recruitment</a></p>\r\n<p><a href=\"http://www.cencenelec.eu/research/pages/default.aspx\"><strong>CEN </strong></a>and <a href=\"http://www.cencenelec.eu/research/pages/default.aspx\"><strong>CENELEC</strong></a>, the European Standards Organisations, <strong>advise you how to tackle standarisation in your project proposal.</strong> Contact the CEN-CENELEC Research Helpdesk at&nbsp;<a href=\"mailto: research@cencenelec.eu \">research@cencenelec.eu&nbsp;</a></p>\r\n<p>&nbsp;</p>\r\n<p><br />\r\n<a href=\"http://www.imi.europa.eu/content/partner-search\"><br />\r\n<br />\r\n</a></p>", "links": [{"callIdentifier": "H2020-JTI-IMI2-2015-08-single-stage-1", "status": "Closed", "criterionType": "SubFundingScheme", "criterionTypeDescription": "subfunding schemes", "criterionCode": "IMI2-RIA", "criterionDescription": "Research and Innovation action", "url": "https://ec.europa.eu/research/participants/submission/manage/secure/createdraft?callId=H2020-JTI-IMI2-2015-08-single-stage&amp;sfs=IMI2-RIA&amp;preregtype=Topic&amp;preregvalue=IMI2-2015-08-01", "startDate": "Dec 23, 2015 2:40:00 PM"}], "additionalDossiers": [{"callId": 52392567260, "id": 165843787, "title": "IMI2 Call 8 4th cut-off date - Flash Call Info Report ", "sectionId": 52392567260, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 244952, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2015-08-01/1795115-imi2_call_8-_4th_cut-off_date_-_falsh_call_info_en.pdf", "id": 1795115, "fileName": "IMI2 Call 8- 4th cut-off date - Falsh call info_EN.pdf", "common": false, "crc32": 1655988314}]}, {"callId": 52392567260, "id": 165843788, "title": "IMI2 Call 8 5th cut-off date - Flash Call Info Report", "sectionId": 52392567260, "translationFiles": [{"language": "en", "mimeType": "application/pdf", "fileSize": 84348, "docPath": "https://ec.europa.eu/info/funding-tenders/opportunities/docs/cap/h2020/imi2-2015-08-01/1822644-imi2_call_8-_5th_cut-off_date_-_flash_call_info_report_en.pdf", "id": 1822644, "fileName": "IMI2 Call 8- 5th cut-off date - Flash Call Info Report_EN.pdf", "common": false, "crc32": 2064248024}]}], "infoPackDossiers": [], "callDetailsJSONItem": {"latestInfos": [{"approvalDate": "Jun 7, 2018 12:44:16 PM", "lastChangeDate": "Jun 7, 2018 12:44:16 PM", "content": "<p class=\"MsoNormal\"><span style=\"font-size:11.0pt;line-height:107%;&#10;font-family:&quot;Calibri&quot;,sans-serif;mso-ascii-theme-font:minor-latin;mso-fareast-font-family:&#10;Calibri;mso-fareast-theme-font:minor-latin;mso-hansi-theme-font:minor-latin;&#10;mso-bidi-font-family:&quot;Times New Roman&quot;;mso-bidi-theme-font:minor-bidi;&#10;mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA\">An overview of the evaluation results (<a href=\"http://ec.europa.eu/research/participants/portal/doc/call/h2020/imi2-2015-08-01/1822642-imi2_call_8-_5th_cut-off_date_-_flash_call_info_report_en.pdf\" target=\"_blank\">flash call info &ndash; IMI2 Call 8 &ndash; single stage &ndash; &nbsp;5th cut-off date</a>) is now available under the call &lsquo;Additional documents&rsquo; tab</span></p>"}, {"approvalDate": "Mar 16, 2018 3:25:46 PM", "lastChangeDate": "Mar 16, 2018 3:25:46 PM", "content": "<p class=\"MsoNormal\"><b><span style=\"font-size: 10pt; font-family: &quot;Arial&quot;,sans-serif\"><o:p>A total number of 4 proposals were submitted in response to the IMI2 Call 8 - 5th cut-off date.</o:p></span></b></p>"}, {"approvalDate": "Nov 14, 2017 4:50:29 PM", "lastChangeDate": "Nov 14, 2017 4:50:29 PM", "content": "<p class=\"MsoNormal\"><font face=\"Arial, sans-serif\"><span style=\"font-size: 13.3333px;\"><b>An overview of the evaluation results (<a href=\"http://ec.europa.eu/research/participants/portal/doc/call/h2020/imi2-2015-08-01/1795115-imi2_call_8-_4th_cut-off_date_-_falsh_call_info_en.pdf\" target=\"_blank\">flash call info &ndash; IMI2 Call 8 &ndash; single stage&nbsp; - 4th cut-off date</a>) is now available under the call &lsquo;Additional documents&rsquo; tab.&nbsp;</b></span></font><b><span style=\"font-size:10.0pt;font-family:&quot;Arial&quot;,sans-serif\">&nbsp;<o:p></o:p></span></b></p>"}, {"approvalDate": "Dec 23, 2015 2:48:52 PM", "lastChangeDate": "Dec 23, 2015 2:48:52 PM", "content": "The submission session is now available for: IMI2-2015-08(IMI2-RIA)"}], "hasForthcomingTopics": false, "hasOpenTopics": false, "allClosedTopics": true}}}